Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Alzheimer'S Research & Therapy|November 12, 2022
Performance of a fully-automated Lumipulse plasma phospho-tau181 assay for Alzheimer's diseaseEdward N Wilson, Christina B Young, Javier Ramos Benitez, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2024
Longitudinal cognitive performance of participants with sporadic early onset Alzheimer's disease from LEADSDustin B Hammers, Ani Eloyan, Alexander Taurone, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2024
Plasma Aβ42/Aβ40 is sensitive to early cerebral amyloid accumulation and predicts risk of cognitive decline across the Alzheimer's disease spectrumAlexandra N Trelle, Christina B Young, Hillary Vossler, et al.
The Journal of Prevention of Alzheimer'S Disease|February 16, 2025
Characterizing and validating 12-month reliable cognitive change in Early-Onset Alzheimer's Disease for use in clinical trialsDustin B Hammers, Jane Musema, Ani Eloyan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2024
Differences in baseline cognitive performance between participants with early-onset and late-onset Alzheimer's disease: Comparison of LEADS and ADNIDustin B Hammers, Ani Eloyan, Maryanne Thangarajah, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 30, 2026
Relationship between age and severity of cognitive impairment at diagnosis for early-onset and late-onset Alzheimer's disease: Comparison of LEADS and ADNIDustin B Hammers, Ani Eloyan, Maryanne Thangarajah, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 18, 2026
Cognitive dispersion profiles and prediction of cognitive change in early-onset dementias: Results from LEADSDustin B Hammers, Elodie Foster, Ani Eloyan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 6, 2023
Pathogenic variants in the Longitudinal Early-onset Alzheimer's Disease Study cohortKelly N H Nudelman, Trever Jackson, Malia Rumbaugh, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 6, 2026
Criterion and convergent validity of plasma biomarkers in early-onset Alzheimer's disease: Initial findings from LEADSDustin B Hammers, Angelina Polsinelli, Ani Eloyan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 31, 2023
Profiling baseline performance on the Longitudinal Early-Onset Alzheimer's Disease Study (LEADS) cohort near the midpoint of data collectionDustin B Hammers, Ani Eloyan, Alexander Taurone, et al.
Pageof 6